Carregant...
Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials
This study evaluates the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses.
Guardat en:
| Publicat a: | JAMA Intern Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Medical Association
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450302/ https://ncbi.nlm.nih.gov/pubmed/30830216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.7661 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|